A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies

Project: Research

Project Details

StatusActive
Effective start/end date7/05/2113/05/26

Keywords

  • phase 1 and 2 study
  • clinical trial
  • treatment safety
  • treatment efficacy
  • myeloid leukemia